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D-galactoseinduced neurotoxicityiswell knownmodel forstudyingagingandrelated oxidativedamageandmemoryimpairment.
Aging is a biological process, characterized by the gradual loss of physiological functions by unknown mechanism. Centella
asiatica, Indian pennywort has been documented in the treatment of various neurological disorders including aging. Therefore,
present study has been conducted in order to explore the possible role of Centella asiatica against D-galactose induced cognitive
impairment,oxidativeandmitochondrialdysfunctioninmice.ChronicadministrationofD-galactose(100mg/kgs.c.)foraperiod
of six weeks signiﬁcantly impaired cognitive task (both in both Morris water maze and elevated plus maze) and oxidative defense
(Increased lipid peroxidation, nitrite concentration and decreased activity of superoxide dismutase, catalase and non-protein
thiols) and impaired mitochondrial complex (I, II and III) enzymes activities as compared to sham group. Six weeks Centella
asiatica (150 and 300mg/kg, p.o) treatment signiﬁcantly improved behavioral alterations, oxidative damage and mitochondrial
enzyme complex activities as compared to contro l (D-galactose). Centella asiatica also attenuated enhanced acetylcholine esterase
enzyme level in D-galactose senescence mice. Present study highlights the protective eﬀect of Centella asiatica against D-galactose
induced behavioral, biochemical and mitochondrial dysfunction in mice.
1.Introduction
Aging is a slow and gradual biological process, associated
with various morphological and biochemical changes in
biological system [1]. Aging diminishes homeostasis and
increases vulnerability to cognitive dysfunctions in addition
to physical, mental, or social activities in human beings.
Aging also accompanied by changes in membrane fatty acid
composition including decrease levels of polyunsaturated
fatty acid (PUFAs) such as arachidonic acid (AA). A
correlation between the concentration of AA and long-term
potentiation suggests that oxidation depletion of AA may be
related to cognitive deﬁcits in animal. It is now well known
that many age-related behavioral changes in motor and
cognitive performance occur even in the absence of speciﬁc,
age-related, neurodegenerative diseases such as Alzheimer
diseaseorParkinson disease[2].Thebehavioraldysfunctions
have been proposed to be associated with a decreased
mitochondrial electron transfer complex activity with aging
[3]. Some factors implicated in aging include chronological
risk factors, telomere shortening, advanced glycation end-
products, and free radicals damage. Brain senescence plays
an important role in cognitive dysfunction which is com-
monlyassociatedwithmanyneurodegenerativedisorders.D-
galactose is a normal reducing sugar in body. Galactose is
normally metabolized by D-galactokinase and galactose-1-
phosphate uridyltransferase in animals, but over-supply of
D-galactose results in abnormality of metabolism [4]. D-
galactose converts into galactitol, which is not metabolized
by above enzymes but accumulate in the cell, leading to
osmotic stress and production of reactive oxygen species [5].
Researchers have a strong opinion that D-galactose reacts
with the free amines of amino acids in proteins and peptides
to form advanced glycation end products (AGE), which in
turn causes activation of receptor for advanced glycation
end products (RAGE). This sequence of events results
an oxidative stress and cellular damage [6–8]. However,
our earlier study had reported that D-galactose toxicity is
associated with mitochondria dysfunction in mice [9]. The
implicationofmitochondria bothasproducersandastargets2 International Journal of Alzheimer’s Disease
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Figure 1: Drug treatment was given as per the ﬂow diagram.
of ROS has been the basis for the mitochondrial theory of
aging [10]. The theory postulates that random alterations of
mitochondrial DNA (mtDNA) in somatic cells are responsi-
b l ef o rt h ee n e r g e t i cd e c l i n ea c c o m p a n yi n gs e n e s c e n c e .I th a s
also been proposed that accumulation of somatic mutations
of mtDNA, induced by exposure to ROS, leads to errors
in the mtDNA-encoded polypeptides [11]. These errors are
stochastic and randomly transmitted during mitochondrial
andcelldivision.Theconsequenceofthesealterations,which
aﬀect exclusively the mitochondrial complexes involved in
energyconservation,wouldbedefectiveelectrontransferand
oxidative phosphorylation. Respiratory chain defects may be
associated with increased ROS production, thus establishing
a vicious circle [12].
Centella asiatica (CA) L. Urban (syn. Hydrocotyle asi-
atica L.) belonging to family Apiaceae (Umbelliferae) is a
psychoactive medicinal plant, being used from centuries in
Ayurvedic system of medicine as a medhya rasayna [13]. It
hasbeenreported topossess variousbiologicalactivitiessuch
asstimulatory-nervine tonic,rejuvenant,sedative,anxiolytic,
and intelligence promoting property [14]. Asiaticoside,
active constitute of Centella asiatica has been reported as
a dementia-treating agent and cognitive enhancer [15].
Asiaticoside has been found to have therapeutic value
against β-amyloid neurotoxicity [16]. Previous reports also
demonstrated that Centella asiatica leaf extract involved in
the morphology of hippocampal CA3 and amygdal neuronal
dendriticarborizationinneonatalrats[17,18].Besideexper-
iments it has been shown to improve learning and memory
in mice during early postnatal developmental period [19].
CA has been reported to contain more than 70 constituents
such as caﬀeicacid derivative,ﬂavonoid,triterpenoids and in
particular quercetin and kaempferol, catechin, rutin, sterols,
and lipid, some of which have been proved to have a potent
antioxidants [20]. Despite the beneﬁcial eﬀects of CA, its
therapeuticeﬀectagainstmitochondrialdysfunctionandfree
radicalmediatedtoxicityhas notbeenwell understoodsofar.
Therefore, the present study has been designed to
explore the possible role of Centella asiatica against D-
galactose-induced cognitive dysfunction, oxidative damage,
and mitochondrial dysfunction in senescence mice.
2.Materialsand Methods
2.1. Animals. Male Laca mice (25–30g), 2-3 months old,
(Central Animal House, Panjab University, Chandigarh)
were used. Animals were acclimatized to the laboratory con-
ditions room temperature prior to the experiment. Animals
were kept under standard condition of 12 hour light/dark
cycle with food and water ad libitum in plastic cages with
soft bedding. Experiment was carried out between 9.00 and
17.00h. The protocol was approved by the Institutional
Animal Ethics Committee and was carried out in accordance
with the Indian National ScienceAcademyGuidelines for the
use and care of animals.
2.2. Drugs and Treatment Schedule. D-galactose (CDH,
India) solution and standardized aqueous extract of Centella
asiatica (CA) (Dabur Research Foundation, Ghaziabad,
India) was used. D-galactose was dissolved in distilled
water for subcutaneous (s.c.) administration. CA extract
suspended in 0.25% w/v sodium carboxy-methyl-cellulose
and administered orally in a dose of 1mL/100g body weight.
Animals were randomized into ﬁve groups, each consists of
12 animals.
(I) Na¨ ıve group received 0.5% sodium carboxymethyl
cellulose.
(II) D-galactose-treated group received 100mg/kg of D-
galactose administered subcutaneously.
(III) CA (300mg/kg, p.o.) was administered to the per se
groups.
(IV) CA (150mg/kg, p.o.) were administered to D-
galactose-treated mice.
(V) CA (300mg/kg, p.o.) were administered to D-
galactose-treated mice.
The doses of CA and D-galactose were selected based on
our report in the literature [9, 21, 22]. The study was carried
out for a period of 42 days (6 weeks) as in Figure 1.International Journal of Alzheimer’s Disease 3
2.3. Behavioral Assessments
2.3.1. Assessment of Cognitive Performance
(a) Morris Water Maze Task. The acquisition and retention
of memory was evaluated by using Morris water maze [21].
Morris water maze consisted of large circular pool (150cm
in diameter, 45cm in height, ﬁlled to a depth of 30cm
with water at 28 ± 1◦C). Pool was divided into four equal
quadrants with the help of two threads, ﬁxed at right angle
to each other. The pool was placed in illuminated light
room among the several colored clues. These external clues
remained unchanged throughout the experimental period
and used as reference memory. A circular platform (4.5cm
diameter) was placed in one quadrant of the pool, 1cm
above the water level during the acquisition phase. A similar
platform was placed 1cm below the water level for retention
phase. The position of the platform was not changed in any
quadrant during assessment of both phases. Each animal
was subjected to four consecutive trials with gap of 5min.
The mouse was gently placed in the water of the pool
between quadrants, facing the wall of the pool with drop
location,change for each trial, and allowed 120s tolocate the
platform. Then, it was allowed tostay on the platform for the
following 20s. If animal failed to reach the platform within
120s, same was guided to reach the platform.
MazeAcquisition Phase (Training). Animals received a train-
ing session consisting of 4 trials on day 20. Starting position
was diﬀerent in all the four trials. The time taken by the
mouse to reach the visual platform was taken as the initial
acquisition latency (IAL). At the end of each trial, mice were
returned to their respective home cages.
Maze Retention Phase (Testing for Retention of the Learned
Task). Following 24 hour (day 21) and 21 days (day 42)
after IAL, mouse was released randomly at one of the edges
facing the wall of the pool to assess for memory retention.
Time taken by mice to ﬁnd the hidden platform on day 21
and 42 following start of D-galactose administration was
recorded, termed as ﬁrst retention latency (1st RL) and
second retention latency (2nd RL), respectively.
(b) Elevated Plus Maze Paradigm. The elevated plus maze
consistsoftwooppositewhite openarms(16×5cm),crossed
with two closed walls (16×5cm) with 12cm high walls. The
arms were connected with a central square of dimensions
5 × 5cm. The entire maze was placed 25cm high above the
ground. Acquisition of memory was tested on day 20. A
mouse was placed individually at one end of the open arm
facing away from the central square. The time taken by the
animal to move from the open arm to the closed arm was
recorded as the initial transfer latency (ITL). Animals were
allowed to explore the maze for 10s after recording ITL. If
animal did not enter the enclosed arm within 90s, same was
guided to the enclosed arm and ITL was recorded as 90s.
Retention of memory was assessed by placing the mouse
in an open arm on day 21 and day 42 of the ITL, termed
as the ﬁrst retention transfer latency (1st RTL) and second
retention transfer latency (2nd RTL), respectively [23].
2.3.2. Assessment of Gross Behavioral Activity. Gross behav-
ioral activity was observed at weekly intervals. Each animal
was placed in a square (30cm) closed arena equipped with
infrared light sensitive photocells using digital actophotome-
ter. The animal was observed for a period of 5min and
expressed as counts/5min. The apparatus was placed in a
darkened, light and sound attenuated and ventilated test
room [21].
2.4. Mitochondrial Complex Estimation
Isolation of Mice Brain Mitochondria. The whole brain
(excludingcerebellum)wasusedformitochondrial isolation.
Mice brain mitochondria were isolated by diﬀerential cen-
trifugation [24]. The mice brain is homogenized in 10mL of
homogenizing buﬀer containing 225mM mannitol, 75mM
sucrose, 5mM HEPES, 1mM EGTA, and 1mg/mL BSA, pH
7.4. The homogenate is brought to 30mL with the same
buﬀer and centrifuged at 2000g for 3min at 4◦C. The pellet
is discarded, and the supernatant is divided into 2 tubes and
centrifuged at 12000g for 10min. The pellet containing the
mixture of synaptosomes and mitochondria is suspended in
10mL of homogenization buﬀer containing 0.02% digitonin
to lyse the synaptosomes followed by centrifugation at
12000g for 10min to pellet down both extrasynaptosomal
and intrasynaptosomal mitochondria. The mitochondrial
pellet iswashed twiceinthesame buﬀerwithoutEGTA,BSA,
or digitonin.
2.4.1. Complex-I (NADH Dehydrogenase Activity). COM-
PLEX-Iwasmeasuredspectrophotometrically bythemethod
of King and Howard [25]. The method involves catalytic
oxidation of NADH to NAD+ with subsequent reduction
of cytochrome C. The reaction mixture contained 0.2M
glycyl glycine buﬀer pH 8.5, 6mM NADH in 2mM glycyl
glycine buﬀer and 10.5mM cytochrome C. The reaction
was initiated by addition of requisite amount of solubilized
mitochondrial sample and followed absorbance change at
550nm for 2min.
2.4.2. Complex-II (Succinate Dehydrogenase (SDH) Activity).
SDH was measured spectrophotometrically according to
King [26]. The method involves oxidation of succinate
by an artiﬁcial electron acceptor, potassium ferricyanide.
The reaction mixture contained 0.2M phosphate buﬀer pH
7.8, 1% BSA, 0.6M succinic acid, and 0.03M potassium
ferricyanide. The reaction was initiated by the addition of
mitochondrial sample, and absorbance change was followed
at 420nm for 2min.
2.4.3. COMPLEX-III (MTT Ability). The MTT assay is
based on the reduction of (3-(4,5-dimethylthiazol-2-yl)-
2, 5-diphenyl-H-tetrazolium bromide (MTT) by hydro-
genase activity in functionally intact mitochondria. The
MTT reduction rate was used to assess the activity of the4 International Journal of Alzheimer’s Disease
mitochondrial respiratory chain in isolated mitochondria by
the method of Liu et al. [27]. Brieﬂy, 100μLm i t o c h o n d r i a l
samples were incubated with 10μLM T Tf o r3h o u r sa t
37◦C. The blue formazan crystals were solubilized with
dimethylsulfoxide and measured by an ELISA reader at
580nm ﬁlter.
2.5. Biochemical Assessment. Biochemical tests were con-
ducted 24hrs after last behavioral test. The animals were
sacriﬁced by decapitation. Brains were removed and rinsed
with ice-cold isotonic saline. Brains were then homogenized
with ice-cold 0.1mmol/L phosphate buﬀer (pH 7.4). The
homogenates (10% w/v) were then centrifuged at 10,000g
for 15min and the supernatant so formed was used for the
biochemical estimations.
2.5.1. Measurement of Lipid Peroxidation. The extent of lipid
peroxidation in the brain was determined quantitatively
by performing the method as described by0020Wills [28].
The amount of malondialdehyde (MDA) was measured by
reaction with thiobarbituric acid at 532nm using Perkin
Elmer Lambda 20 spectrophotometer.
2.5.2. Estimation of Nitrite. The accumulation of nitrite
in the supernatant, an indicator of the production of
nitric oxide, was determined by a colorimetric assay with
Greiss reagent (0.1% N-(1-napththyl) ethylene diamine
dihydrochloride, 1% sulphanilamide and 5% phosphoric
acid.) [29]. The absorbance was measured at 540nm using
Perkin Elmer Lambda 20 spectrophotometer. The concen-
tration of nitrite in the supernatant was determined from
sodium nitrite standard curve.
2.5.3. Estimation of Non Protein Thiols (NP-SH). NP-SH was
estimated according to the method described by Ellman
[30]. A 1mL supernatant was precipitated with 1mL of 4%
sulphosalicylic acid and cold digested for 1 hour at 4◦C. The
samples were then centrifuged at 1,200g for 15min at 4◦C.
To 1mL of the supernatant obtained, 2.7mL of phosphate
buﬀer (0.1mmol/L, pH 8) and 0.2mL of 5, 5  dithio-bis (2-
nitrobenzoic acid) was added. The yellow color developed
was measured at 412nm using Perkin Elmer Lambda 20
spectrophotometer.
2.5.4. Superoxide Dismutase Activity. Superoxide dismutase
(SOD)activity was assayed by the method of Kono [31]. The
assay system consists of EDTA 0.1mM, sodium carbonate
50mM, and 96mM of nitro blue tetrazolium (NBT). In the
cuvette, 2mL of the above mixture, 0.05mL of hydroxy-
lamine, and 0.05mL of the supernatant was added and auto-
oxidation of hydroxylamine was measured for 2min at 30s
interval by measuring absorbance at 560nm using Perkin
Elmer Lambda 20 spectrophotometer.
2.5.5. Catalase Activity. Catalase activity was assessed by the
method of Luck [32], wherein the breakdown of H2O2 is
measured. Brieﬂy, assay mixture consists of 3mL of H2O2
phosphatebuﬀerand0.05mLofthesupernatantofthetissue
homogenate. The change in absorbance was recorded for
2min at 30s interval at 240nm using Perkin Elmer Lambda
20 spectrophotometer.
2.5.6. Glutathione-S-Transferase Activity. The activity of
glutathione-s-transferase was assayed by the method of
Habig and Jakoby [33]. Brieﬂy, the assay mixture consisted
of2.7mLofphosphatebuﬀer,0.1mLofreducedglutathione,
0.1mL of 1-chloro-2, 4-dinitrobenzene (CDNB)as substrate
and 0.1mL of supernatant. The increase in the absorbance
was recorded at 340nm for 5min at 1min interval using
Perkin Elmer Lambda 20 spectrophotometer.
2.5.7. Estimation of Acetyl Cholinesterase (AChE) Activity.
AchE is a marker of loss of cholinergic neurons in the
forebrain. The AchE activity was assessed by Ellman method
[34]. The assay mixture contained 0.05mL of supernatant,
3mL of sodium phosphate buﬀer(pH 8), 0.1mL of acetylth-
iocholine iodide, and 0.1mL of DTNB (Ellman reagent).
T h ec h a n g ei na b s o r b a n c ew a sm e a s u r e df o r2 m i na t
30s interval at 412nm using Perkin Elmer Lambda 20
spectrophotometer.
2.5.8. Protein Estimation. The protein content was estimated
by Biuret method [35] using bovine serum albumin as a
standard.
2.6. Statistical Analysis. Values are expressed as mean ±
S.E.M. The behavioral assessment data were analyzed by a
repeated measures two-way analysis of variance (ANOVA)
with drug-treated groups as between and sessions as the
within-subjects factors. The biochemical estimations were
separately analyzed by one-way ANOVA. Post hoc compar-
isons between groups were made using Tukey’s test. P<. 05
was considered signiﬁcant.
3.Results
3.1. Centella Asiatica (CA) Improved on Behavioral Alteration
in D-Galactose-Treated Mice
(I) Morris Water Maze. D-galactose-treated mice signif-
icantly delayed acquisition latency to reach the visual
platform as compared to na¨ ıve group, indicating memory
deﬁcits. CA (150 & 300mg/kg) treatment signiﬁcantly
improved memory performance (shortened mean acqui-
sition latency) on day 19 and 20 (P<. 05) in D-
galactose-treated group. Following training, visual platform
was kept 1cm below water level. D-galactose treatment
signiﬁcantly delayed mean acquisition latency and retention
latencies (1st and 2nd on days 21 and 42, resp.) to escape
onto the hidden platform as compared to na¨ ıve group.
These results suggest that D-galactose caused signiﬁcant
cognitive impairment. Further, chronic CA treatment (150
& 300mg/kg) signiﬁcantly improved memory performance
(increased memory retention) on 1st and 2nd RL on
days 21 and 42, respectively, as compared to D-galactose-
treated mice. However, CA (300mg/kg) per se treatmentInternational Journal of Alzheimer’s Disease 5
6 5 4 3 2 1
(week)
0
50
100
150
200
250
300
350
C
o
u
n
t
s
/
5
m
i
n
Na¨ ıve
D-gal (100)
CA (300)
CA (150) + D-gal (100)
CA (300) + D-gal (100)
Figure 2: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg, p.o.)
on locomotoractivity in D-galactose-treated mice. Values are mean
± S.E.M. Data was analyzed by two-way ANOVA.
did not inﬂuence any acquisition and retention latencies as
compared to na¨ ıve animals (Table 1).
(II) Elevated Plus Maze. In the present study, D-galactose-
treated group signiﬁcantly increased ITL as compared to
na¨ ıve group on day 20. Further, D-galactose-treated group
showed a signiﬁcant delayed 1st RTL and 2nd RTL on days
21 and 42, respectively, as compared to na¨ ıve group, demon-
strating that chronic D-galactose-induced marked memory
impairment. Chronic CA (150 & 300mg/kg) treatment
signiﬁcantly shortened acquisition latency on day 20 as well
as mean retention transfer latencies to enter close arm on
days 21 and 42 as compared to control (D-galactose-treated
group) (P<. 05).However, CA (150mg/kg) per se treatment
did not show any signiﬁcant alteration in both acquisition as
well as retention as compared to na¨ ıve group (Table 2).
3.2. Centella asiatica (CA) on Locomotor Activity in D-
GalactoseTreatedMice. D-galactose-treatment didnotinﬂu-
ence signiﬁcantly the locomotor activity as compared to
na¨ ıve animals. Chronic administration of CA (300mg/kg)
persetreatmentaswellasCA(150and300mg/kg)treatment
in D-galactose-treated mice did not cause any alteration in
the locomotor activity as compared to control (D-galactose)
(Figure 2).
3.3. Antioxidant Eﬀect of Centella asiatica (CA) in D-
Galactose-Treated Mice. Chronic administration of D-
galactose signiﬁcantly raised MDA and nitrite concentration,
and caused depletion of NP-SH, glutathione-S-tranferase,
superoxide dismutase, and catalase level as compared to
na¨ ıve mice (P<. 05). However, chronic CA (150 and
300mg/kg, p.o.) treatment signiﬁcantly attenuated the
oxidative damage as indicated by reduced MDA, nitrite
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Figure 3: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg, p.o.)
on acetylcholinesterase activity in D-galactose-treated mice. Values
are mean ± S.E.M. aP<. 05 as compared to na¨ ıve group; bP<. 05
as compared to D-gal-treated group; cP<. 05 as compared to CA
(150)+D-galgroup;(repeated measuresone-wayANOVAfollowed
by Tukey’s test for multiple comparisons).
concentration, and restoration of NP-SH, glutathione-S-
transferase, superoxide dismutase, and catalase level as
compared to control group (D-gal-treated group) levels.
Further, CA (300mg/kg, p.o.) per se treatment did not
produce any signiﬁcant eﬀect on oxidative stress parameter
as compared to na¨ ıve mice (Table 3).
3.4. Reversal of Increased Brain Acetyl Cholinesterase Levels by
Centella asiatica (CA) in D-Galactose-Treated Mice. Chronic
administration D-galactose caused a signiﬁcant increase in
acetyl cholinesterase activity as compared to na¨ ıve mice
(P<. 05). However, chronic CA (150 and 300mg/kg,
p.o.) treatment signiﬁcantly decreased acetylcholinesterase
activity as compared to D-galactose-treated mice. Further,
there was no alteration in acetyl cholinesterase activity in CA
(300mg/kg, p.o.) per se treatment as compared to na¨ ıve mice
(Figure 3).
3.5.Centellaasiatica(CA)ImprovedonMitochondrialEnzyme
AlterationinD-Galactose-TreatedMice. Chronicadministra-
tion of D-galactose caused marked mitochondrial enzyme
complex dysfunction and signiﬁcantly decreased NADH
dehydrogenase, succinate dehydrogenase, and MTT ability
as compared to na¨ ıve mice (P<. 05). Chronic CA (150
and 300mg/kg, p.o.) administration to D-galactose-treated
mice signiﬁcantly prevented the mitochondrial dysfunction.
Further, there were no alteration in the brain mitochondrial
levels of NADH dehydrogenase, succinate dehydrogenase,
and MTT ability in CA (150 and 300mg/kg, p.o.) per se
treatment as compared to na¨ ıve mice (Figure 4).
4.Discussion
The present study demonstrates that Centella asiatica extract
preventsmemorydeﬁcitsagainstD-galactose-inducedsenes-
cence in mice.6 International Journal of Alzheimer’s Disease
Table 1: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg, p.o.) on memory performance in Morris water maze in D-galactose-treated
mice.
Treatment (mg/Kg) Day 20 (IAL) Day 21 (1st RL) Day 42 (2nd RL)
Na¨ ıve 48.1 ± 2.9 17.3 ± 3.2 12.3 ± 1.4
D-gal (100) 49.8 ± 3.0 58.0 ± 2.2a 55.1 ± 1.7a
CA (300) 48.6 ± 2.6 12.5 ± 2.5 9.5 ± 2.4
CA (150) + D-gal (100) 46.5 ± 2.56 43.0 ± 2.7b 40.6 ± 2.6b
CA (300) + D-gal (100) 46.3 ± 2.7 28.5 ± 2.5b,c 25.6 ± 2.4b,c
The initial acquisition latencies (IAL) on day 20 and retention latencies on days 21 (1st RL) and 42 (2nd RL) following D-gal concurrent treatment were
observed. Values are mean ± S.E.M. aP<. 05 as compared to naive group; bP<. 05 as compared to D-gal-treated group; cP<. 05 as compared to CA (150) +
D-gal group (repeated measures two-way ANOVA followed by Tukey’s test for multiple comparisons).
Table 2: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg, p.o.) on memory performance in elevated plus maze paradigm in D-galactose-
treated mice.
Treatment (mg/ Kg) Day 20 (ITL) Day 21 (1st RTL) Day 42 (2nd RTL)
Na¨ ıve 77.5 ± 2.4 15.0 ± 2.7 10.0 ± 2.5
D-gal (100) 77.6 ± 2.3 87.8 ± 2.6a 84.3 ± 2.3a
CA (300) 79.8 ± 2.6 13.5 ± 2.4 11.0 ± 2.2
CA (150) + D-gal (100) 78.3 ± 2.7 50.6 ± 2.6b 47.0 ± 2.5b
CA (300) + D-gal (100) 79.0 ± 2.6 40.8 ± 2.6b,c 38.0 ± 2.3b,c
The initial acquisition latencies (IAL) on day 20 and retention latencies on days 21 (1st RL) and 42 (2nd RL) following AlCl3 concurrent treatment were
observed. Values are mean ± S.E.M. aP<. 05 as compared to naive group; bP<. 05 as compared to D-gal-treated group; cP<. 05 as compared to CA (150) +
D-gal group (repeated measures two-way ANOVA followed by Tukey’s test for multiple comparisons).
D-galactose plays a prime role in the pathogenesis of
aging. Various hypotheses have been put forward to explain
the mechanism of action of D-galactose in aging including
glycometabolismblock,formationofadvancedglycationend
product (AGE), and free radical injury with the evidence of
increase levels of malondialdehyde, lipofuscin, decrease in
SOD, glutathione peroxidase activity, and decrease in NP-
SH level [36–38]. D-galactose administration mimics some
characters of cognitive dysfunction and oxidative damage;
therefore, it is gradually accepted by people and used in
age-related disorders like AD. In our study, D-galactose
senescence mice spent a longer time in ﬁnding the hidden
platform during the retrieval trial in the Morris water maze
test which indicates impairment of memory. Observation
has been further strengthened by EPM test in which D-
galactose showed more latency time to enterinto closed arm.
In our previous report, we found that D-galactose produced
memory impairment in mice for 6 weeks [9, 21]. Earlier, it
has been reported that rodents injected with D-galactose for
6–10 weeks shows progressive deterioration of learning and
memory capacity and increases production of free radicals
in the brain [6]. In our study, chronic administration of D-
galactose resulted in a marked oxidative stress as indicated
by increasing lipid peroxidation, nitrite concentration, and
depletion of NP-SH levels, catalase, superoxide dismutase,
and glutathione-s-transferase activity, suggesting oxidative
damage. Afterwards, growing evidence revealed there was
learning and memory impairment and neuropathological
changes like oxidative damage occurred in the brain of
rodents treated with D-galactose [39, 40]. The cholinergic
system has been implicated in the age-related disorders like
AD. Chronic administration of D-galactose showed marked
increase of actetylcholine estrase (AChE) enzyme, one of
the speciﬁc cholinergic markers in aging mice. Recently,
Zhongetal.reportedthatAChEactivity,which isresponsible
for degredation of acetyl cholinei ns y n a p t i cc l e f ti n c r e a s e d
signiﬁcantly in D-galactose-treated mice [41]. Additionally,
CA leaf extract has been reported to improve spatial learning
performance and enhance memory retention in neonatal
rats during growth spurt period, but also found eﬃcient in
enhancinghippocampal CA3 neuronaldendriticarborization
in rats [17, 18].
It has been shown that aging is associated with a
markeddeclineinmitochondrialfunction,characterizedbya
decrease in oxidative phosphorylation and ATP synthesis, an
increase in mtDNA (mitochondrial deoxyribonucleic acid)
mutations, an increase in abnormal mitochondrial cristae
structures, and a marked rise in free radical production, all
of which may predispose to age-related disorders [42–44]. It
is well known that energy production, realized by oxidative
phosphorylation activity, occurs in mitochondria and is
catalysed by membrane bound protein complexes, namely
NADH-ubiquinol oxidoreductase (Complex I), succinate-
ubiquinol oxidoreductase (Complex II), and ubiquinol
cytochrome c oxidoreductase (Complex III). Mitochondrial
oxidative damage is based on the fact that electron leakage
from electron transport chain (ETC), mainly through com-
plex I and complex III and the amount of O2
•− increases
dramaticallyifthesecomplexesareinhibited[45].Theresults
of the present study indicate that chronic administration
of D-galactose results in mitochondrial dysfunction as
indicatedbydecreaseintheNADHdehydrogenase,succinate
dehydrogenase activity and MTT ability.
Chronic administration of extract of CA was found
to improve not only the memory impairment but also
reduced oxidative damage induced by chronic D-galactoseInternational Journal of Alzheimer’s Disease 7
Table 3: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg, p.o.) on D-gal-induced oxidative stress parameters in rat brain.
Treatment
(mg/kg)
MDA levels
nmol MDA/mg
of protein (% of
control)
Nitrite levels
μmol/mg of
protein (% of
control)
Non protein
Thiol nmol/mg
of protein (% of
control)
Catalase μmol of
hydrogen peroxide
decomposed/min/mg of
protein (% of control)
Superoxide
dismutase
Units/mg of
protein (% of
control)
Glutathione-S-
transferase nmol of
CDNB
conjugated/min/mg
of protein (% of
control)
Na¨ ıve 0.1768 ± 0.04
(100)
216.8 ± 30.06
(100)
0.0653 ± 0.005
(100) 0.709 ± 0.04 (100) 48.252 ± 3.19
(100) 97.9 ± 5 (100)
D-gal (100) 0.5965 ± 0.05a
(338.63)
605.83 ± 28.32a
(279.44)
0.0256 ± 0.003a
(39.203) 0.147 ± 0.018a (20.73) 13.873 ± 2.11a
(28.75) 37.8 ± 5.3a (38.61)
CA (300) 0.172 ± 0.03
(97.82)
218 ± 26.7
(100.55)
0.0648 ± 0.004
(99.23) 0.703 ± 0.03 (99.15) 47.22 ± 3.111
(97.86) 99.9 ± 5.2 (102.04)
CA (150) +
D-gal (100)
0.486 ± 0.03b
(247.88)
456 ± 16.2b
(210.33)
0.041 ± 0.001b
(62.78) 0.309 ± 0.023b (43.58) 21.93 ± 2.049b
(45.44) 47.67 ± 2.3b (48.69)
CA (300) +
D-gal (100)
0.279 ± 0.04b,c
(157.8)
353.83 ± 18.6b,c
(163.2)
0.051 ± 0.001b,c
(78.1) 0.427 ± 0.018b,c (60.22) 35.872 ± 2.05b,c
(74.34) 64.6 ± 1.8b,c (65.98)
Values are mean ± S.E.M. aP<. 05 as compared to naive group; bP<. 05 as compared to D-gal-treated group; cP<. 05 as compared to CA (150) group+
D-gal group (repeated measures one-way ANOVA followed by Tukey’s test for multiple comparisons).
Number of viable
cell /well
mmole/mg
protein
nmole of NADH
oxidized/min/mg
protein
0
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Figure 4: Eﬀect of Centella asiatica (CA; 150 and 300mg/kg,
p.o.) on NADH Dehydrogenase activity, succinate dehydrogenase
activity, and MTT ability in D-galactose-treated mice. Values are
mean ± S.E.M. aP<. 05 as compared to na¨ ıve group; bP<. 05
as compared to D-gal treated group; cP<. 05 as compared to CA
(150) + D-gal group (repeated measures one-way ANOVA followed
by Tukey’s test for multiple comparisons).
administration. A previous study showed that diﬀerent
accessions of Centella asiatica exhibited a high antioxidative
activity that was comparable to that exhibited by both α-
tocopherol and BHT [46]. In our study, CA signiﬁcantly
protected the elevated MDA level and nitric oxide of D-
galactose aging mice. Glutathione is an endogenous antiox-
idant present in the reduced form within the cells. It has
beenshowntoreactwithfreeradicalsandpreventgeneration
of hydroxyl free radicals. In the present study, CA restored
the NP-SH and glutathione-s-transferase leveland activity of
SOD, catalase in brain of D-galactose-treated mice indicate
that CA extract participates in the elimination of free
radicals induced by D-galactose. These ﬁndings promoted
to us to examine that CA would render protection of
mitochondrial dysfunction induced by D-galactose in mice.
C u r r e n te v i d e n c es u g g e s t st h a tm i t o c h o n d r i aa r eam a j o r
source of intracellular ROS and are particularly vulnerable
to oxidative stress and its potential connection with mito-
chondrial enzyme alteration, have been implicated in brain
aging. Our result showed CA extract markedly upregulated
NADH dehydrogenase, succinate dehydrogenase activity,
and MTT ability in D-galactose-induced senescence mice.
There is another interesting ﬁnding that chronic treatment
with CA extract reversed the AChE activity of D-galactose-
induced aging mice which reﬂects that this compound may
improve dysfunction of the cholinergic system long term
exposed to oxidative stress. The present study highlights that
CA attenuates D-galactose-induced behavioral, biochemical,
and mitochondrial dysfunction by involving antioxidant
and mitochondrial pathways in senescence mice. However,
further cellular studies are required to understand the eﬀect
of CA on oxidative stress and mitochondrial pathways and
the interaction in diﬀerent experimental system.
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